← Open Payments lookup

LUKMANAFIS BABAJIDE: Open Payments

NPI 1134657067 · RANCHO MIRAGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,982 in 54 payments from 14 companies in 2025. Trend: 2023 $436 · 2024 $4,051 · 2025 $2,982

Food & beverage: $2,873Education: $109
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc10$1,157
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$336
Axsome Therapeutics, Inc.5$231
E.R. Squibb & Sons, L.L.C.4$218
ABBVIE INC.7$188
Otsuka America Pharmaceutical, Inc.3$174
Vanda Pharmaceuticals Inc.9$167
Alkermes, Inc.2$153
Teva Pharmaceuticals USA, Inc.2$147
Supernus Pharmaceuticals, Inc.3$80

Products named: INVEGA SUSTENNA, SPRAVATO, CAPLYTA, Auvelity, REXULTI, VRAYLAR, FANAPT, ARISTADA.

Industry payments across CA — which companies pay providers there.